AngioDynamics, Inc. v. C.R. Bard, Inc. et al

Filing 432

ORDER: with rulings on objections to deposition designations for witnesses Germano, Powers, and Shepherd. The Court notes that designations should not include attorneys speaking; the Court will not address future objections in that regard. Signed by Chief Judge Brenda K. Sannes on 9/16/2022. (Attachments: # 1 Additional rulings for Witness Germano) (nmk)

AngioDynamics v. Bard, N.D.N.Y. 17-598
Bard's September 14, 2022 Submission to Court

Case 1:17-cv-00598-BKS-CFH Document 432 Filed 09/16/22 Page 1 of 7

Bard's Objections and Counter-Designations to AngioDynamics' 9/13/2022 Affirmative Designations for Germano, Powers, and Shepherd
AngioDynamics'
Bard's Objections to Affirmative
Bard's Counter-Designations
Court’s Ruling
Name of Deponent
Date of Testimony
Affirmative
Designations
Designations
5:8 -5:9
Germano, Salvatore
January 14, 2020
8:7 -10:14
Germano, Salvatore
January 14, 2020
13:4 -14:2
Germano, Salvatore
January 14, 2020
Designation includes attorney speaking
Sustained:
14:15
-15:25
84:4-7,
84:9-17,
84:19
objection
(15:5-6)
remove 15:5-6
Germano, Salvatore
January 14, 2020
Designation includes attorney speaking
Sustained:
16:2 -16:16
objection (16:11)
remove 16:11
Germano, Salvatore
January 14, 2020
Designation includes attorney speaking
Sustained:
18:6 -18:24
objection (18:11)
remove 18:11
Germano, Salvatore
January 14, 2020

Germano, Salvatore
Germano, Salvatore
Germano, Salvatore
Germano, Salvatore
Germano, Salvatore
Germano, Salvatore
Germano, Salvatore

Germano, Salvatore
Germano, Salvatore
Germano, Salvatore
Germano, Salvatore
Germano, Salvatore
Germano, Salvatore

January 14, 2020
January 14, 2020
January 14, 2020
January 14, 2020
January 14, 2020
January 14, 2020
January 14, 2020

Speculation

Sustained as to
31:5-8

Hearsay; assumes facts not in evidence;
designation includes attorney speaking objection
(73:14)

Sustained

Designation includes attorney speaking
objection (74:22)

Sustained:
remove 74:22

Hearsay

Sustained as to
218:15-20

23:5 -23:18
29:25 -30:10
30:22 -31:8
31:9 -31:23
47:10 -47:15
52:25 -53:10
67:4 -67:15

January 14, 2020

73:11 -73:21

January 14, 2020
January 14, 2020
January 14, 2020

74:14 -74:24
76:8 -77:6
208:5 -208:8

January 14, 2020
January 14, 2020

Hearsay, speculation

Sustained as to
23:13-18 ("The
time it takes…")

218:11 -218:20
221:23 -222:9

AngioDynamics v. Bard, N.D.N.Y. 17-598
Bard's September 14, 2022 Submission to Court

Name of Deponent

Germano, Salvatore
Germano, Salvatore
Germano, Salvatore

Case 1:17-cv-00598-BKS-CFH Document 432 Filed 09/16/22 Page 2 of 7

Date of Testimony

January 14, 2020
January 14, 2020
January 14, 2020

AngioDynamics'
Bard's Objections to Affirmative
Affirmative
Designations
Designations

227:20 -230:9
253:19 -253:23
255:16 -255:23

Germano, Salvatore
Germano, Salvatore
Germano, Salvatore

January 14, 2020
January 14, 2020
January 14, 2020

255:24 -257:25
277:8 -277:19
278:9 -278:20

Powers, Kelly

September 26, 2019

35:1-4

Powers, Kelly

September 26, 2019

36:1-23

Powers, Kelly

Powers, Kelly

Powers, Kelly

Powers, Kelly

Powers, Kelly
Powers, Kelly
Powers, Kelly
Powers, Kelly

September 26, 2019

September 26, 2019

September 26, 2019

September 26, 2019

September 26, 2019
September 26, 2019
September 26, 2019
September 26, 2019

Hearsay

Hearsay; speculation; assumes facts not in
evidence

Exhibit more prejudicial than probative (P-051)
Exhibit more prejudicial than probative (P-051)

Bard's Counter-Designations

Court’s Ruling

226:23-227:4, 230:10-232:24

Sustained as to
228:20-230:9
(hearsay)

258:5-260:12, 261:6-263:17, 263:19264:17
276:21-277:7, 277:20-278:8
278:21-279:16
35:18-21, 37:3-5
35:18-21, 37:3-5

123:13-16

305:5-10, 305:12-308:8, 308:10309:17, 310:5-311:5, 311:6-312:16,
312:17-314:19

124:24-25

305:5-10, 305:12-308:8, 308:10309:17, 310:5-311:5, 311:6-312:16,
312:17-314:19

125:1 -125:5

305:5-10, 305:12-308:8, 308:10309:17, 310:5-311:5, 311:6-312:16,
312:17-314:19

126:11-13

305:5-10, 305:12-308:8, 308:10309:17, 310:5-311:5, 311:6-312:16,
312:17-314:19

129:1-9
135:16-19
139:13-22
254:14-23

305:5-10, 305:12-308:8, 308:10309:17, 310:5-311:5, 311:6-312:16,
312:17-314:19
135:20-25
311:6-312:16
314:20-315:13

403 (prejudicial, confusing); foundation

Sustained as to
256:7-13, 256:21257:25

Sustained
Sustained

Overruled

AngioDynamics v. Bard, N.D.N.Y. 17-598
Bard's September 14, 2022 Submission to Court

Name of Deponent

Powers, Kelly
Powers, Kelly

Powers, Kelly

Case 1:17-cv-00598-BKS-CFH Document 432 Filed 09/16/22 Page 3 of 7

Date of Testimony

September 26, 2019
September 27, 2019

September 27, 2019

AngioDynamics'
Bard's Objections to Affirmative
Affirmative
Designations
Designations

302:23-303:11
6:9-11

7:14-25

More prejudicial than probative; 401/402 relevance, violates assurance that designations
would be "targeted to elements of
AngioDynamics' case" (ECF 356); foundation;
misstates testimony; misstates document

Bard's Counter-Designations

Court’s Ruling

Sustained
(confusing)
303:23-304:5, 309:18-310:4, 311:6312:16

403 - prejudicial, 401/402 - relevance, violates
assurance that designations would be "targeted
to elements of AngioDynamics' case" (ECF 356)

Overruled
(relevant to
impeachment/bias
)

403 - prejudicial, 401/402 - relevance, violates
assurance that designations would be "targeted
to elements of AngioDynamics' case" (ECF 356)

Overruled
(relevant to
impeachment/bias
)

Powers, Kelly
Powers, Kelly
Powers, Kelly
Powers, Kelly
Powers, Kelly

September 27, 2019
September 27, 2019
September 27, 2019
September 27, 2019
September 27, 2019

8:1-7
32:7-34:11
42:15-42:24
43:21-44:15
45:10-14

September 27, 2019

48:17-23

improper hypothetical, speculation, calls for
legal conclusion (re: patent infringement)

Overruled

Powers, Kelly

49:12-23

improper hypothetical, speculation, calls for
legal conclusion (re: patent infringement)

Overruled

50:1-11
54:6-23
55:4-8
55:16-21

improper hypothetical, speculation, calls for
legal conclusion (re: patent infringement)
403 (prejudicial, confusing)
403 (prejudicial, confusing)
403 (prejudicial, confusing)

Overruled

Powers, Kelly

Powers, Kelly
Powers, Kelly
Powers, Kelly
Powers, Kelly

September 27, 2019

September 27, 2019
September 27, 2019
September 27, 2019
September 27, 2019

45:17-46:7, 46:24-47:2

Overruled
Overruled
Overruled

AngioDynamics v. Bard, N.D.N.Y. 17-598
Bard's September 14, 2022 Submission to Court

Name of Deponent

Case 1:17-cv-00598-BKS-CFH Document 432 Filed 09/16/22 Page 4 of 7

Date of Testimony

AngioDynamics'
Bard's Objections to Affirmative
Affirmative
Designations
Designations

Bard's Counter-Designations

403 - prejudicial, 401/402 - relevance, violates
assurance that designations would be "targeted
to elements of AngioDynamics' case" (ECF 356)

Powers, Kelly

September 27, 2019

74:20-77:9

Overruled

P-060 801/802 - Hearsay (e.g., page 2-3, "she
shared a few things with me" and subsequent
email)
Sustained (any
minimal probative
value
substantially
outweighed by
403 concerns)

403 - prejudicial, 401/402 - relevance, violates
assurance that designations would be "targeted
to elements of AngioDynamics' case" (ECF 356)

Powers, Kelly

September 27, 2019

87:17-89:6

P-060 801/802 - Hearsay (e.g., page 2-3, "she
shared a few things with me" and subsequent
email)

89:8-17

403 - prejudicial, 401/402 - irrelevant, violates
assurance that designations would be "targeted
to elements of AngioDynamics' case" (ECF 356)

Powers, Kelly
Powers, Kelly
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland

September 27, 2019
September 27, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019

89:18-89:23
114:8-115:10
6:9 -6:11
28:9 -29:22
33:14 -33:23
35:7 -35:11
37:8 -37:10
37:14 -37:14
38:9 -38:23

Court’s Ruling

Sustained

P-060 801/802 - Hearsay (e.g., page 2-3, "she
shared a few things with me" and subsequent
email)
115:11-16
P-295 Relevance

30:9-19

Foundation

Overruled
Overruled

37:16-17

AngioDynamics v. Bard, N.D.N.Y. 17-598
Bard's September 14, 2022 Submission to Court

Case 1:17-cv-00598-BKS-CFH Document 432 Filed 09/16/22 Page 5 of 7

Name of Deponent

Date of Testimony

Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland

November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019

Shepherd, Roland
Shepherd, Roland

November 23, 2019
November 23, 2019

AngioDynamics'
Affirmative
Designations
39:12 -40:11
40:12 -40:23
41:1 -42:6
46:1 -47:15
63:18 -64:9
64:12 -64:15
64:19 -64:20
64:24 -65:3
72:1 -72:13
72:22 -72:25
78:2 -78:4
79:2 -79:4
88:14 -88:16
99:15 -99:25
119:2 -119:14
119:15 -119:22
124:11 -124:16
136:18 -137:3
140:24 -141:3
141:8 -141:8
141:9 -141:9
141:12 -142:5
150:12 -150:25
155:21 -156:4
157:15 -158:1
158:2 -158:9
159:9 -159:25

Bard's Objections to Affirmative
Designations
Speculation

Bard's Counter-Designations

42:23-43:3

Vague, speculation

Relevance, foundation
Relevance, foundation
Relevance, foundation

Court’s Ruling

Overruled

Overruled

65:13-66:13, 66:19-25, 71:2-17
72:15-21
73:1-14
89:14-16, 89:19-25, 90:20-91:2
89:14-16, 89:19-25, 90:20-91:2

Overruled
Overruled
Overruled

109:10-111:8, 120:15-121:3
124:21-125:10
137:4-10, 137:12-138:20

142:13-22
P-087 403 (prejudicial, confusing)
P-087 403 (prejudicial, confusing)
P-087 403 (prejudicial, confusing)
P-087 403 (prejudicial, confusing)

160:6 -160:20

Designation incomplete (answer with no
question)
P-087 403 (prejudicial, confusing)

160:23 -161:4

P-087 403 (prejudicial, confusing)

Overruled
Overruled
Overruled
Overruled
Sustained, subject
to cure by
including
question
Overruled

AngioDynamics v. Bard, N.D.N.Y. 17-598
Bard's September 14, 2022 Submission to Court

Case 1:17-cv-00598-BKS-CFH Document 432 Filed 09/16/22 Page 6 of 7

Name of Deponent

Date of Testimony

Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland

November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019

Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland

November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019

AngioDynamics'
Affirmative
Designations
161:6 -161:23
169:22 -170:2
170:6 -170:12
172:18 -172:24
173:16 -173:25
177:15 -178:7
180:2 -180:6
180:9 -180:9
180:11 -180:23
181:7 -181:12
181:15 -182:3
183:4 -184:2
186:5 -186:15
186:24 -187:2
188:17 -188:20
193:4 -194:10
195:15 -195:24
196:1 -196:3
203:19 -203:22
209:22 -210:4

Bard's Objections to Affirmative
Designations
P-087 403 (prejudicial, confusing)

Bard's Counter-Designations

170:3-5
170:13-16

Court’s Ruling
Overruled

178:8-179:6

Speculation, vague
Speculation, vague

184:4-6

Overruled
Overruled

187:3, 187:6-8
Foundation
Foundation
Relevance

210:7 -210:19

Relevance

211:5 -211:7
211:8 -211:8
211:14 -211:24
212:23 -213:22
214:2 -215:8
215:23 -216:16
217:20 -218:14
220:5 -220:8
222:7 -223:10
224:1 -228:8

P-290 Relevance
P-290 Relevance
P-290 Relevance
P-290 Relevance
P-290 Relevance
P-290 Relevance
P-290 Relevance

Overruled
Overruled
Overruled

217:1-14
218:15-21

228:11-19

Sustained as to
210:13-19
Overruled
Overruled
Overruled
Overruled
Overruled
Overruled
Overruled

AngioDynamics v. Bard, N.D.N.Y. 17-598
Bard's September 14, 2022 Submission to Court

Case 1:17-cv-00598-BKS-CFH Document 432 Filed 09/16/22 Page 7 of 7

Name of Deponent

Date of Testimony

Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland
Shepherd, Roland

November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019
November 23, 2019

AngioDynamics'
Bard's Objections to Affirmative
Affirmative
Designations
Designations
229:11 -229:13
229:15 -230:24
229:25 -230:24
239:5 -239:8
240:20 -240:24
241:5 -242:16
242:17 -244:1

Dated: September 16, 2022

Bard's Counter-Designations

Court’s Ruling